{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:35:22Z","timestamp":1785893722248,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012349","name":"School for Public Health Research","doi-asserted-by":"publisher","award":["PD-SPH-2015"],"award-info":[{"award-number":["PD-SPH-2015"]}],"id":[{"id":"10.13039\/501100012349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Applied Research Collaboration North East and North Cumbria","award":["NIHR200173"],"award-info":[{"award-number":["NIHR200173"]}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["NIHR Advanced Fellowship"],"award-info":[{"award-number":["NIHR Advanced Fellowship"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012621","name":"University College London Hospitals Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid use is a major public health concern across the globe. Opioid use and subsequent access to care is often shaped by co-occurring issues faced by people using opioids, such as deprivation, mental ill-health, and other forms of substance use. We investigated the role of social deprivation and comorbid mental health diagnoses in predicting re-engagement with substance use services or contact with crisis and inpatient services for individuals with opioid use disorder in secondary mental health care in inner-city London.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective cohort study which followed individuals diagnosed with a first episode of opioid use disorder who accessed substance use services between September 2015 and May 2020 for up to 12 months, using anonymised electronic health records. We employed negative binominal regression and Cox proportional survival analyses to assess associations between exposures and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Comorbid mental health diagnoses were associated with higher contact rates with crisis\/inpatient services among people with opioid use disorder: incidence rate ratios (IRR) and 95% confidence intervals (CI) were 3.91 (1.74\u20139.14) for non-opioid substance use comorbidity, 8.92 (1.81\u201364.4) for a single comorbid mental health diagnosis, and 15.9 (5.89\u201347.5) for multiple comorbid mental health diagnoses. Social deprivation was not associated with contact rates with crisis\/inpatient services within this sample. Similar patterns were found with time to first crisis\/inpatient contact. Social deprivation and comorbid mental health diagnoses were not associated with re-engagement with substance use services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Comorbid substance and mental health difficulties amongst people with an opioid use disorder led to earlier and more frequent contact with crisis\/inpatient mental health services during the first 12 months of follow up. Given the common co-occurrence of mental health and substance use disorders among those who use opioids, a better understanding of their wider needs (such as social, financial and other non-medical concerns) will ensure they are supported in their treatment journeys.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13011-023-00568-5","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T09:02:18Z","timestamp":1698310938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Investigating social deprivation and comorbid mental health diagnosis as predictors of treatment access among patients with an opioid use disorder using substance use services: a prospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Emma A","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Minot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Kirkbride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"568_CR1","unstructured":"United Nations Office on Drugs and Crime. World Drug Report. 2022: Booklet 3 Drug Market Trends Cannabis Opioids. United Nations publications; 2022. Available from: https:\/\/www.unodc.org\/res\/wdr2022\/MS\/WDR22_Booklet_3.pdf."},{"issue":"3","key":"568_CR2","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/S2468-2667(22)00043-3","volume":"7","author":"The Lancet Public Health","year":"2022","unstructured":"The Lancet Public Health. Opioid Overdose crisis: time for a radical rethink. Lancet Public Health. 2022;7(3):e195. https:\/\/doi.org\/10.1016\/S2468-2667(22)00043-3.","journal-title":"Lancet Public Health"},{"issue":"8","key":"568_CR3","doi-asserted-by":"publisher","first-page":"e0221153","DOI":"10.1371\/journal.pone.0221153","volume":"14","author":"B Rosner","year":"2019","unstructured":"Rosner B, Neicun J, Yang JC, Roman-Urrestarazu A. Opioid prescription patterns in Germany and the global opioid epidemic: systematic review of available evidence. PLoS ONE. 2019;14(8):e0221153. https:\/\/doi.org\/10.1371\/journal.pone.0221153.","journal-title":"PLoS ONE"},{"issue":"4","key":"568_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid Overdose crisis. Curr Opin Psychiatry. 2021;34(4):344.","journal-title":"Curr Opin Psychiatry"},{"key":"568_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.15585\/mmwr.mm6643e1","volume":"66","author":"J Halpin","year":"2017","unstructured":"Halpin J, Mattson C, Goldberger B, Gladden R. Deaths involving fentanyl, fentanyl analogs, and U-47700 10 States, July December 2016. MMWR Morb Mortal Wkly Rep. 2017;66:1197\u2013202.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"568_CR6","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1016\/S2468-2667(21)00254-1","volume":"7","author":"D Lewer","year":"2022","unstructured":"Lewer D, Brothers TD, Van Hest N, Hickman M, Holland A, Padmanathan P, et al. Causes of death among people who used illicit opioids in England, 2001\u201318: a matched cohort study. The Lancet Public Health. 2022;7(2):e126\u2013e35.","journal-title":"The Lancet Public Health"},{"key":"568_CR7","unstructured":"Office for Health Improvement & Disparities. Adult substance misuse treatment statistics 2020 to 2021: report. 2021. Available from: https:\/\/www.gov.uk\/government\/statistics\/substance-misuse-treatment-for-adults-statistics-2020-to-2021\/adult-substance-misuse-treatment-statistics-2020-to-2021-report."},{"issue":"7","key":"568_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jamapsychiatry.2020.0103","volume":"77","author":"G Lewis","year":"2020","unstructured":"Lewis G, Dykxhoorn J, Karlsson H, Khandaker GM, Lewis G, Dalman C, et al. Assessment of the role of IQ in associations between Population Density and Deprivation and Nonaffective psychosis. JAMA Psychiatry. 2020;77(7):729\u201336. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.0103.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"568_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamapsychiatry.2017.3582","volume":"75","author":"L Richardson","year":"2018","unstructured":"Richardson L, Hameed Y, Perez J, Jones PB, Kirkbride JB. Association of Environment with the risk of developing psychotic disorders in rural populations: findings from the Social Epidemiology of psychoses in East Anglia Study. JAMA Psychiatry. 2018;75(1):75\u201383. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.3582.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"568_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1940-0640-7-228","volume":"7","author":"TA Rowe","year":"2012","unstructured":"Rowe TA, Jacapraro JS, Rastegar DA. Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems. Addict Sci Clin Pract. 2012;7(1):22. https:\/\/doi.org\/10.1186\/1940-0640-7-228.","journal-title":"Addict Sci Clin Pract"},{"key":"568_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","volume":"74","author":"ZM Weinstein","year":"2017","unstructured":"Weinstein ZM, Kim HW, Cheng DM, Quinn E, Hui D, Labelle CT, et al. Long-term retention in Office based opioid treatment with buprenorphine. J Subst Abuse Treat. 2017;74:65\u201370. https:\/\/doi.org\/10.1016\/j.jsat.2016.12.010.","journal-title":"J Subst Abuse Treat"},{"key":"568_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.09.017","volume":"181","author":"CB Simon","year":"2017","unstructured":"Simon CB, Tsui JI, Merrill JO, Adwell A, Tamru E, Klein JW. Linking patients with buprenorphine treatment in primary care: predictors of engagement. Drug Alcohol Depend. 2017;181:58\u201362. 0.1016\/j.drugalcdep.2017.09.017.","journal-title":"Drug Alcohol Depend"},{"key":"568_CR13","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2147\/NDT.S129480","volume":"13","author":"T Rosic","year":"2017","unstructured":"Rosic T, Naji L, Bawor M, Dennis BB, Plater C, Marsh DC, et al. The impact of comorbid psychiatric disorders on Methadone maintenance treatment in opioid use disorder: a prospective cohort study. Neuropsychiatr Dis Treat. 2017;13:1399\u2013408. https:\/\/doi.org\/10.2147\/NDT.S129480.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"568_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/ADM.0000000000000057","volume":"8","author":"A Fareed","year":"2014","unstructured":"Fareed A, Eilender P, Ketchen B, Buchanan-Cummings AM, Scheinberg K, Crampton K, et al. Factors affecting noncompliance with buprenorphine maintenance treatment. J Addict Med. 2014;8(5):345\u201350. https:\/\/doi.org\/10.1097\/ADM.0000000000000057.","journal-title":"J Addict Med"},{"key":"568_CR15","volume-title":"An evidence review of the outcomes that can be expected of drug misuse treatment in England","author":"P Burkinshaw","year":"2017","unstructured":"Burkinshaw P, Knight J, Anders P, Eastwood B, Musto V, White M, et al. An evidence review of the outcomes that can be expected of drug misuse treatment in England. London: Public Health England; 2017."},{"key":"568_CR16","doi-asserted-by":"publisher","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews. 2003;CD002209. https:\/\/doi.org\/10.1002\/14651858.CD002209. 2.Art. No.","DOI":"10.1002\/14651858.CD002209"},{"key":"568_CR17","doi-asserted-by":"publisher","first-page":"215013272093201","DOI":"10.1177\/2150132720932017","volume":"11","author":"SA Hooker","year":"2020","unstructured":"Hooker SA, Sherman MD, Lonergan-Cullum M, Sattler A, Liese BS, Justesen K, et al. Mental Health and Psychosocial needs of patients being treated for opioid Use Disorder in a primary care Residency Clinic. J Prim Care Community Health. 2020;11:2150132720932017.","journal-title":"J Prim Care Community Health"},{"key":"568_CR18","doi-asserted-by":"publisher","unstructured":"Macfarlane GJ, Beasley M, Jones GT, Stannard C. The epidemiology of regular opioid use and its association with mortality: prospective cohort study of 466 486 UK biobank participants. EClinicalMedicine. 2020;21. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100321.","DOI":"10.1016\/j.eclinm.2020.100321"},{"key":"568_CR19","doi-asserted-by":"publisher","unstructured":"Nowakowska M, Zghebi SS, Perisi R, Chen L-C, Ashcroft DM, Kontopantelis E. Association of socioeconomic deprivation with opioid prescribing in primary care in England: a spatial analysis. J Epidemiol Commun Health. 2020;jech\u20132020. https:\/\/doi.org\/10.1136\/jech-2020-214676.","DOI":"10.1136\/jech-2020-214676"},{"issue":"5","key":"568_CR20","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3122\/jabfm.2019.05.190012","volume":"32","author":"RE Cantone","year":"2019","unstructured":"Cantone RE, Garvey B, O\u2019Neill A, Fleishman J, Cohen D, Muench J, et al. Predictors of medication-assisted treatment initiation for opioid Use Disorder in an Interdisciplinary Primary Care Model. J Am Board Fam Med. 2019;32(5):724\u201331. https:\/\/doi.org\/10.3122\/jabfm.2019.05.190012.","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"568_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13011-019-0221-6","volume":"14","author":"CM Morton","year":"2019","unstructured":"Morton CM. Community social deprivation and availability of substance use treatment and mutual aid recovery groups. Subst Abuse Treat Prev Policy. 2019;14(1):33. https:\/\/doi.org\/10.1186\/s13011-019-0221-6.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"568_CR22","doi-asserted-by":"publisher","first-page":"e0190703","DOI":"10.1371\/journal.pone.0190703","volume":"13","author":"N Werbeloff","year":"2018","unstructured":"Werbeloff N, Osborn DPJ, Patel R, Taylor M, Stewart R, Broadbent M, et al. The Camden & Islington Research Database: using electronic mental health records for research. PLoS ONE. 2018;13(1):e0190703. https:\/\/doi.org\/10.1371\/journal.pone.0190703.","journal-title":"PLoS ONE"},{"key":"568_CR23","unstructured":"Ministry of Housing, Communities & Local Government. English indices of deprivation 2015. 2015. Available from: https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015."},{"key":"568_CR24","unstructured":"Official census and labour market statistics. 2011 Census. 2011. Available from: https:\/\/www.nomisweb.co.uk\/sources\/census_2011."},{"issue":"5","key":"568_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1192\/bjp.187.5.401","volume":"187","author":"J Allardyce","year":"2005","unstructured":"Allardyce J, Gilmour H, Atkinson J, Rapson T, Bishop J, McCreadie R. Social fragmentation, deprivation and urbanicity: relation to first-admission rates for psychoses. The Br J Psychiatry. 2005;187(5):401\u20136. https:\/\/doi.org\/10.1192\/bjp.187.5.401.","journal-title":"The Br J Psychiatry"},{"issue":"1","key":"568_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/schbul\/sbs151","volume":"40","author":"JB Kirkbride","year":"2012","unstructured":"Kirkbride JB, Jones PB, Ullrich S, Coid JW. Social Deprivation, Inequality, and the Neighborhood-Level incidence of psychotic syndromes in East London. Schizophr Bull. 2012;40(1):169\u201380. https:\/\/doi.org\/10.1093\/schbul\/sbs151.","journal-title":"Schizophr Bull"},{"key":"568_CR27","volume-title":"R: a language and environment for statistical computing","author":"R Development Core Team","year":"2023","unstructured":"Development Core Team R. R: a language and environment for statistical computing. Volume R 431, ed ed. Vienna, Austria: R Foundation for Statistical Computing; 2023.","edition":"ed"},{"key":"568_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.drugpo.2018.10.013","volume":"64","author":"TC Chen","year":"2019","unstructured":"Chen TC, Chen LC, Kerry M, Knaggs RD. Prescription opioids: Regional variation and socioeconomic status - evidence from primary care in England. Int J Drug Policy. 2019;64:87\u201394. https:\/\/doi.org\/10.1016\/j.drugpo.2018.10.013.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"568_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S2215-0366(18)30471-1","volume":"6","author":"HJ Curtis","year":"2019","unstructured":"Curtis HJ, Croker R, Walker AJ, Richards GC, Quinlan J, Goldacre B. Opioid prescribing trends and geographical variation in England, 1998\u20132018: a retrospective database study. Lancet Psychiatry. 2019;6(2):140\u201350. https:\/\/doi.org\/10.1016\/S2215-0366(18)30471-1.","journal-title":"Lancet Psychiatry"},{"issue":"668","key":"568_CR30","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.3399\/bjgp18X695057","volume":"68","author":"L Mordecai","year":"2018","unstructured":"Mordecai L, Reynolds C, de Donaldson LJ. Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study. Br J Gen Pract. 2018;68(668):e225\u2013e33. https:\/\/doi.org\/10.3399\/bjgp18X695057.","journal-title":"Br J Gen Pract"},{"key":"568_CR31","doi-asserted-by":"publisher","first-page":"112585","DOI":"10.1016\/j.socscimed.2019.112585","volume":"242","author":"A Yamamoto","year":"2019","unstructured":"Yamamoto A, Needleman J, Gelberg L, Kominski G, Shoptaw S, Tsugawa Y. Association between homelessness and opioid Overdose and opioid-related hospital admissions\/emergency department visits. Soc Sci Med. 2019;242:112585. https:\/\/doi.org\/10.1016\/j.socscimed.2019.112585.","journal-title":"Soc Sci Med"},{"issue":"1","key":"568_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12954-021-00539-8","volume":"18","author":"K Milaney","year":"2021","unstructured":"Milaney K, Passi J, Zaretsky L, Liu T, O\u2019Gorman CM, Hill L, et al. Drug use, homelessness and health: responding to the opioid Overdose crisis with housing and harm reduction services. Harm Reduct J. 2021;18(1):92. https:\/\/doi.org\/10.1186\/s12954-021-00539-8.","journal-title":"Harm Reduct J"},{"issue":"8","key":"568_CR33","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/add.14599","volume":"114","author":"MG Harris","year":"2019","unstructured":"Harris MG, Bharat C, Glantz MD, Sampson NA, Al-Hamzawi A, Alonso J, et al. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys. Addiction. 2019;114(8):1446\u201359. https:\/\/doi.org\/10.1111\/add.14599.","journal-title":"Addiction"},{"issue":"1","key":"568_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13011-021-00395-6","volume":"16","author":"K Alexander","year":"2021","unstructured":"Alexander K, Pogorzelska-Maziarz M, Gerolamo A, Hassen N, Kelly EL, Rising KL. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review. Subst Abuse Treat Prev Policy. 2021;16(1):60. https:\/\/doi.org\/10.1186\/s13011-021-00395-6.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"11","key":"568_CR35","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1111\/add.15514","volume":"116","author":"C Bharat","year":"2021","unstructured":"Bharat C, Larney S, Barbieri S, Dobbins T, Jones NR, Hickman M, et al. The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study. Addiction. 2021;116(11):3139\u201352. https:\/\/doi.org\/10.1111\/add.15514.","journal-title":"Addiction"},{"issue":"2","key":"568_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/00952990.2013.842241","volume":"40","author":"ML Griffin","year":"2014","unstructured":"Griffin ML, Dodd DR, Potter JS, Rice LS, Dickinson W, Sparenborg S, et al. Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. Am J Drug Alcohol Abuse. 2014;40(2):157\u201362. https:\/\/doi.org\/10.3109\/00952990.2013.842241.","journal-title":"Am J Drug Alcohol Abuse"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-023-00568-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-023-00568-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-023-00568-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T09:04:31Z","timestamp":1698311071000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-023-00568-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1186\/s13011-023-00568-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.12.15.22283515","asserted-by":"object"}]},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Research Database Oversight Committee with ethical approval for epidemiological research granted by the East of England \u2013 Cambridge Central Research Ethics Committee (19\/EE\/0210). Informed consent was not obtained as data were anonymised.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors consent to publish this manuscript in its current form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"59"}}